Company behind Humira and Skyrizi asks regulators to green-light Rinvoq for psoriatic arthritis
Company behind Humira and Skyrizi asks regulators to green-light Rinvoq for psoriatic arthritis

AbbVie, the North Chicago company behind the longtime blockbuster biologic Humira (adalimumab) and the new biologic Skyrizi (risankizumab-rzaa), has asked the U.S. Food and Drug Administration (FDA) and its European counterpart to approve its rheumatoid arthritis (RA) drug Rinvoq (upadacitinib) for psoriatic arthritis. Rinvoq is a JAK inhibitor administered as Continue Reading…

Our new “Psoriasis Journey” campaign is rolling out
Our new “Psoriasis Journey” campaign is rolling out

Our new Psoriasis Journey campaign is rolling out now to prep for for an official June 8, 2020 launch. On that date, our volunteer patient with severe psoriasis is going to begin one of the cutting-edge psoriasis treatments we’ve been hearing so much about. You can follow along with his Continue Reading…

Want to try an experimental psoriasis treatment for your skin or scalp?
Want to try an experimental psoriasis treatment for your skin or scalp?

Before a doctor can prescribe a treatment, it goes through years of research and testing, including multiple rounds of clinical trials, using volunteer patients to test a potential treatment’s safety and effectiveness. The clinical trials are developed in consultation with government regulators (here, the US Food and Drug Administration, or Continue Reading…

What is ALZUMAb? It’s the psoriasis biologic no one in America has heard of
What is ALZUMAb? It’s the psoriasis biologic no one in America has heard of

Ever heard of Enbrel? Humira? How about ALZUMAb? ALZUMAb (drug name itolizumab) is a “humanized anti-CD6 monoclonal antibody” for adults with active moderate to severe psoriasis. It has a different mechanism of action than the biologics available in the US, Europe, and Japan. It’s only available in India, where it Continue Reading…

Cosentyx goes head to head against Humira in psoriatic arthritis…it’s mostly a draw
Cosentyx goes head to head against Humira in psoriatic arthritis…it’s mostly a draw

Two biologics that work on psoriatic disease differently – Cosentyx (drug name secukinumab, an IL-17a inhibitor) and Humira (drug name adalimumab, a TNF-alpha inhibitor) – were recently tested in a study designed and funded by Novartis, the company behind Cosentyx. The study pitted Cosentyx against Humira for 52 weeks in Continue Reading…

New patient registry PsoProtect for those battling both psoriasis and COVID-19/coronavirus could help provide treatment insights to both ailments
New patient registry PsoProtect for those battling both psoriasis and COVID-19/coronavirus could help provide treatment insights to both ailments

Scientists and physicians in the UK, working with an international coalition of experts and organizations, have launched a web-based registry that will gather health information on people with psoriasis who develop confirmed or suspected COVID-19/coronavirus. The results, if enough doctors participate, could provide important information in the treatment of both Continue Reading…

Do I need to worry about links between psoriasis and Alzheimer’s disease?
Do I need to worry about links between psoriasis and Alzheimer’s disease?

You may have seen the headlines: “Psoriasis tied to higher Alzheimer’s disease risk.” Great. Just another thing to worry about thanks to psoriasis, right? But when you dig into the research, you realize it’s mostly just the usual media hype: there’s no need to panic the next time you misplace Continue Reading…

Amgen to test Otezla as possible COVID-19 coronavirus treatment
Amgen to test Otezla as possible COVID-19 coronavirus treatment

Biotech giant Amgen, known in the psoriasis world for its longtime blockbuster Enbrel (etanercept), a biologic used in the treatment of psoriasis and psoriatic arthritis, has announced that the company “plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus.” Continue Reading…

Coronavirus and psoriasis: what you need to know

Short summary • Take seriously the social distancing, hand-washing, face covering, and other recommendations from the CDC so we can stop the spread of COVID-19/coronavirus. • Those with psoriasis and/or psoriatic arthritis should check in with their doctor to ask if treatment alterations should be made in light of the Continue Reading…

Reading this article about the placebo effect will make you feel better today

Here’s a very interesting item about the placebo effect. Yes, it is fun to hear about experiments in which people can be fooled into feeling better, or worse. But more importantly, this professor and psychologist discusses how a patient’s attitude, and a physician’s warmth and (apparent) competence, can impact our Continue Reading…